(Q35583363)

9 August 2017

1 reference

title

Etanercept-induced systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

9 August 2017

main subject

0 references

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.2003.01411.X

1 April 2024

author name string

Rustin MH

5

1 reference

9 August 2017

V. J. Swale

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616825

1 April 2024

C. M. Perrett

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616825

1 April 2024

C. P. Denton

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616825

1 April 2024

C. M. Black

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616825

1 April 2024

M. H A. Rustin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616825

1 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14616825

1 April 2024

publication date

1 November 2003

1 reference

full work available at URL

9 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2230.2003.01411.x

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.2003.01411.X

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2230.2003.01411.x/fullpdf

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.2003.01411.X

Clinical and Experimental Dermatology

1 April 2024

published in

1 reference

9 August 2017

volume

28

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

604-607

1 reference

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2003.01411.X

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2003.01411.X

New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2003.01411.X

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.2003.01411.X

Autoimmune skin rashes associated with etanercept for rheumatoid arthritis

1 April 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.2003.01411.X

Etanercept-induced subacute cutaneous lupus erythematosus

1 April 2024

6

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.2003.01411.X

Drug-induced systemic lupus erythematosus associated with etanercept therapy

1 April 2024

7

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.2003.01411.X

Drug-induced systemic lupus erythematosus and TNF-alpha blockers

1 April 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.2003.01411.X

Tumor necrosis factor alpha blockers and the induction of anti-DNA autoantibodies

1 April 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.2003.01411.X

Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor alpha-blocking agent: comment on the article by Pisetsky and the letter from Aringer et al

1 April 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.2003.01411.X

1 April 2024

Identifiers

1 reference

9 August 2017

1 reference